 | • レポートコード：GIR-105X09696 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、介入性肺疾患のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。介入性肺疾患の種類別市場規模（気管支鏡、呼吸器内科装置、ENBシステム、胸膜鏡、その他）、用途別市場規模（病院、救急センター、クリニック）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・介入性肺疾患の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Boston Scientific、Olympus、FUJIFILM、Becton, Dickinson and Company、Smiths Group、Cook Medical、Vygon、PENTAX Medical、Clarus Medical、HUGER Medical Instrument、Richard Wolf、Karl Storz、Taewoong Medical、ELLA - CS ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：気管支鏡、呼吸器内科装置、ENBシステム、胸膜鏡、その他 ・用途別分析2016年-2026年：病院、救急センター、クリニック ・介入性肺疾患の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・介入性肺疾患のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・介入性肺疾患のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・介入性肺疾患の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・介入性肺疾患の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Interventional Lung Disease market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Interventional Lung Disease size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Interventional Lung Disease market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Interventional Lung Disease market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Bronchoscopes
Respiratory Endotherapy Devices
ENB Systems
Pleuroscopes
Other
Market segment by Application can be divided into
Hospital
Emergency Center
Clinic
The key market players for global Interventional Lung Disease market are listed below:
Boston Scientific
Olympus
FUJIFILM
Becton, Dickinson and Company
Smiths Group
Cook Medical
Vygon
PENTAX Medical
Clarus Medical
HUGER Medical Instrument
Richard Wolf
Karl Storz
Taewoong Medical
ELLA – CS
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Interventional Lung Disease Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Interventional Lung Disease Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Bronchoscopes
1.2.3 Respiratory Endotherapy Devices
1.2.4 ENB Systems
1.2.5 Pleuroscopes
1.2.6 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Interventional Lung Disease Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Emergency Center
1.3.4 Clinic
1.4 Global Interventional Lung Disease Market Size & Forecast
1.4.1 Global Interventional Lung Disease Sales in Value (2016-2026))
1.4.2 Global Interventional Lung Disease Sales in Volume (2016-2026)
1.4.3 Global Interventional Lung Disease Price by Type (2016-2026) & (USD/Unit)
1.5 Global Interventional Lung Disease Production Capacity Analysis
1.5.1 Global Interventional Lung Disease Total Production Capacity (2016-2026)
1.5.2 Global Interventional Lung Disease Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Interventional Lung Disease Market Drivers
1.6.2 Interventional Lung Disease Market Restraints
1.6.3 Interventional Lung Disease Trends Analysis
2 Manufacturers Profiles
2.1 Boston Scientific
2.1.1 Boston Scientific Details
2.1.2 Boston Scientific Major Business
2.1.3 Boston Scientific Interventional Lung Disease Product and Services
2.1.4 Boston Scientific Interventional Lung Disease Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Olympus
2.2.1 Olympus Details
2.2.2 Olympus Major Business
2.2.3 Olympus Interventional Lung Disease Product and Services
2.2.4 Olympus Interventional Lung Disease Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 FUJIFILM
2.3.1 FUJIFILM Details
2.3.2 FUJIFILM Major Business
2.3.3 FUJIFILM Interventional Lung Disease Product and Services
2.3.4 FUJIFILM Interventional Lung Disease Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Becton, Dickinson and Company
2.4.1 Becton, Dickinson and Company Details
2.4.2 Becton, Dickinson and Company Major Business
2.4.3 Becton, Dickinson and Company Interventional Lung Disease Product and Services
2.4.4 Becton, Dickinson and Company Interventional Lung Disease Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Smiths Group
2.5.1 Smiths Group Details
2.5.2 Smiths Group Major Business
2.5.3 Smiths Group Interventional Lung Disease Product and Services
2.5.4 Smiths Group Interventional Lung Disease Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Cook Medical
2.6.1 Cook Medical Details
2.6.2 Cook Medical Major Business
2.6.3 Cook Medical Interventional Lung Disease Product and Services
2.6.4 Cook Medical Interventional Lung Disease Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Vygon
2.7.1 Vygon Details
2.7.2 Vygon Major Business
2.7.3 Vygon Interventional Lung Disease Product and Services
2.7.4 Vygon Interventional Lung Disease Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 PENTAX Medical
2.8.1 PENTAX Medical Details
2.8.2 PENTAX Medical Major Business
2.8.3 PENTAX Medical Interventional Lung Disease Product and Services
2.8.4 PENTAX Medical Interventional Lung Disease Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Clarus Medical
2.9.1 Clarus Medical Details
2.9.2 Clarus Medical Major Business
2.9.3 Clarus Medical Interventional Lung Disease Product and Services
2.9.4 Clarus Medical Interventional Lung Disease Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 HUGER Medical Instrument
2.10.1 HUGER Medical Instrument Details
2.10.2 HUGER Medical Instrument Major Business
2.10.3 HUGER Medical Instrument Interventional Lung Disease Product and Services
2.10.4 HUGER Medical Instrument Interventional Lung Disease Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.11 Richard Wolf
2.11.1 Richard Wolf Details
2.11.2 Richard Wolf Major Business
2.11.3 Richard Wolf Interventional Lung Disease Product and Services
2.11.4 Richard Wolf Interventional Lung Disease Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.12 Karl Storz
2.12.1 Karl Storz Details
2.12.2 Karl Storz Major Business
2.12.3 Karl Storz Interventional Lung Disease Product and Services
2.12.4 Karl Storz Interventional Lung Disease Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.13 Taewoong Medical
2.13.1 Taewoong Medical Details
2.13.2 Taewoong Medical Major Business
2.13.3 Taewoong Medical Interventional Lung Disease Product and Services
2.13.4 Taewoong Medical Interventional Lung Disease Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.14 ELLA – CS
2.14.1 ELLA – CS Details
2.14.2 ELLA – CS Major Business
2.14.3 ELLA – CS Interventional Lung Disease Product and Services
2.14.4 ELLA – CS Interventional Lung Disease Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Interventional Lung Disease Sales by Manufacturer
3.1 Global Interventional Lung Disease Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Interventional Lung Disease Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Interventional Lung Disease
3.4 Market Concentration Rate
3.4.1 Top 3 Interventional Lung Disease Manufacturer Market Share
3.4.2 Top 6 Interventional Lung Disease Manufacturer Market Share
3.5 Global Interventional Lung Disease Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Interventional Lung Disease Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Interventional Lung Disease Market Size by Region
4.1.1 Global Interventional Lung Disease Sales in Volume by Region (2016-2026)
4.1.2 Global Interventional Lung Disease Revenue by Region (2016-2026)
4.2 North America Interventional Lung Disease Revenue (2016-2026)
4.3 Europe Interventional Lung Disease Revenue (2016-2026)
4.4 Asia-Pacific Interventional Lung Disease Revenue (2016-2026)
4.5 South America Interventional Lung Disease Revenue (2016-2026)
4.6 Middle East and Africa Interventional Lung Disease Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Interventional Lung Disease Sales in Volume by Type (2016-2026)
5.2 Global Interventional Lung Disease Revenue by Type (2016-2026)
5.3 Global Interventional Lung Disease Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Interventional Lung Disease Sales in Volume by Application (2016-2026)
6.2 Global Interventional Lung Disease Revenue by Application (2016-2026)
6.3 Global Interventional Lung Disease Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Interventional Lung Disease Sales by Type (2016-2026)
7.2 North America Interventional Lung Disease Sales by Application (2016-2026)
7.3 North America Interventional Lung Disease Market Size by Country
7.3.1 North America Interventional Lung Disease Sales in Volume by Country (2016-2026)
7.3.2 North America Interventional Lung Disease Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Interventional Lung Disease Sales by Type (2016-2026)
8.2 Europe Interventional Lung Disease Sales by Application (2016-2026)
8.3 Europe Interventional Lung Disease Market Size by Country
8.3.1 Europe Interventional Lung Disease Sales in Volume by Country (2016-2026)
8.3.2 Europe Interventional Lung Disease Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Interventional Lung Disease Sales by Type (2016-2026)
9.2 Asia-Pacific Interventional Lung Disease Sales by Application (2016-2026)
9.3 Asia-Pacific Interventional Lung Disease Market Size by Region
9.3.1 Asia-Pacific Interventional Lung Disease Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Interventional Lung Disease Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Interventional Lung Disease Sales by Type (2016-2026)
10.2 South America Interventional Lung Disease Sales by Application (2016-2026)
10.3 South America Interventional Lung Disease Market Size by Country
10.3.1 South America Interventional Lung Disease Sales in Volume by Country (2016-2026)
10.3.2 South America Interventional Lung Disease Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Interventional Lung Disease Sales by Type (2016-2026)
11.2 Middle East & Africa Interventional Lung Disease Sales by Application (2016-2026)
11.3 Middle East & Africa Interventional Lung Disease Market Size by Country
11.3.1 Middle East & Africa Interventional Lung Disease Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Interventional Lung Disease Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Interventional Lung Disease Typical Distributors
12.3 Interventional Lung Disease Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Interventional Lung Disease Revenue by Type, (USD Million), 2021-2026
Table 2. Global Interventional Lung Disease Revenue by Application, (USD Million), 2021-2026
Table 3. Boston Scientific Basic Information, Manufacturing Base and Competitors
Table 4. Boston Scientific Major Business
Table 5. Boston Scientific Interventional Lung Disease Product and Services
Table 6. Boston Scientific Interventional Lung Disease Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Olympus Basic Information, Manufacturing Base and Competitors
Table 8. Olympus Major Business
Table 9. Olympus Interventional Lung Disease Product and Services
Table 10. Olympus Interventional Lung Disease Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. FUJIFILM Basic Information, Manufacturing Base and Competitors
Table 12. FUJIFILM Major Business
Table 13. FUJIFILM Interventional Lung Disease Product and Services
Table 14. FUJIFILM Interventional Lung Disease Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Becton, Dickinson and Company Basic Information, Manufacturing Base and Competitors
Table 16. Becton, Dickinson and Company Major Business
Table 17. Becton, Dickinson and Company Interventional Lung Disease Product and Services
Table 18. Becton, Dickinson and Company Interventional Lung Disease Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Smiths Group Basic Information, Manufacturing Base and Competitors
Table 20. Smiths Group Major Business
Table 21. Smiths Group Interventional Lung Disease Product and Services
Table 22. Smiths Group Interventional Lung Disease Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Cook Medical Basic Information, Manufacturing Base and Competitors
Table 24. Cook Medical Major Business
Table 25. Cook Medical Interventional Lung Disease Product and Services
Table 26. Cook Medical Interventional Lung Disease Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Vygon Basic Information, Manufacturing Base and Competitors
Table 28. Vygon Major Business
Table 29. Vygon Interventional Lung Disease Product and Services
Table 30. Vygon Interventional Lung Disease Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. PENTAX Medical Basic Information, Manufacturing Base and Competitors
Table 32. PENTAX Medical Major Business
Table 33. PENTAX Medical Interventional Lung Disease Product and Services
Table 34. PENTAX Medical Interventional Lung Disease Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Clarus Medical Basic Information, Manufacturing Base and Competitors
Table 36. Clarus Medical Major Business
Table 37. Clarus Medical Interventional Lung Disease Product and Services
Table 38. Clarus Medical Interventional Lung Disease Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. HUGER Medical Instrument Basic Information, Manufacturing Base and Competitors
Table 40. HUGER Medical Instrument Major Business
Table 41. HUGER Medical Instrument Interventional Lung Disease Product and Services
Table 42. HUGER Medical Instrument Interventional Lung Disease Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Richard Wolf Basic Information, Manufacturing Base and Competitors
Table 44. Richard Wolf Major Business
Table 45. Richard Wolf Interventional Lung Disease Product and Services
Table 46. Richard Wolf Interventional Lung Disease Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Karl Storz Basic Information, Manufacturing Base and Competitors
Table 48. Karl Storz Major Business
Table 49. Karl Storz Interventional Lung Disease Product and Services
Table 50. Karl Storz Interventional Lung Disease Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Taewoong Medical Basic Information, Manufacturing Base and Competitors
Table 52. Taewoong Medical Major Business
Table 53. Taewoong Medical Interventional Lung Disease Product and Services
Table 54. Taewoong Medical Interventional Lung Disease Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. ELLA - CS Basic Information, Manufacturing Base and Competitors
Table 56. ELLA - CS Major Business
Table 57. ELLA - CS Interventional Lung Disease Product and Services
Table 58. ELLA - CS Interventional Lung Disease Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. Global Interventional Lung Disease Sales by Manufacturer (2019-2021e) & (K Units)
Table 60. Global Interventional Lung Disease Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 61. Market Position of Manufacturers in Interventional Lung Disease, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 62. Global Interventional Lung Disease Production Capacity by Company, (K Units): 2020 VS 2021
Table 63. Head Office and Interventional Lung Disease Production Site of Key Manufacturer
Table 64. Global Interventional Lung Disease Sales by Region (2016-2021e) & (K Units)
Table 65. Global Interventional Lung Disease Sales by Region (2021-2026) & (K Units)
Table 66. Global Interventional Lung Disease Revenue by Region (2016-2021e) & (USD Million)
Table 67. Global Interventional Lung Disease Revenue by Region (2021-2026) & (USD Million)
Table 68. Global Interventional Lung Disease Sales by Type (2016-2021e) & (K Units)
Table 69. Global Interventional Lung Disease Sales by Type (2021-2026) & (K Units)
Table 70. Global Interventional Lung Disease Revenue by Type (2016-2021e) & (USD Million)
Table 71. Global Interventional Lung Disease Revenue by Type (2021-2026) & (USD Million)
Table 72. Global Interventional Lung Disease Price by Type (2016-2021e) & (USD/Unit)
Table 73. Global Interventional Lung Disease Price by Type (2021-2026) & (USD/Unit)
Table 74. Global Interventional Lung Disease Sales by Application (2016-2021e) & (K Units)
Table 75. Global Interventional Lung Disease Sales by Application (2021-2026) & (K Units)
Table 76. Global Interventional Lung Disease Revenue by Application (2016-2021e) & (USD Million)
Table 77. Global Interventional Lung Disease Revenue by Application (2021-2026) & (USD Million)
Table 78. Global Interventional Lung Disease Price by Application (2016-2021e) & (USD/Unit)
Table 79. Global Interventional Lung Disease Price by Application (2021-2026) & (USD/Unit)
Table 80. North America Interventional Lung Disease Sales by Country (2016-2021e) & (K Units)
Table 81. North America Interventional Lung Disease Sales by Country (2021-2026) & (K Units)
Table 82. North America Interventional Lung Disease Revenue by Country (2016-2021e) & (USD Million)
Table 83. North America Interventional Lung Disease Revenue by Country (2021-2026) & (USD Million)
Table 84. North America Interventional Lung Disease Sales by Type (2016-2021e) & (K Units)
Table 85. North America Interventional Lung Disease Sales by Type (2021-2026) & (K Units)
Table 86. North America Interventional Lung Disease Sales by Application (2016-2021e) & (K Units)
Table 87. North America Interventional Lung Disease Sales by Application (2021-2026) & (K Units)
Table 88. Europe Interventional Lung Disease Sales by Country (2016-2021e) & (K Units)
Table 89. Europe Interventional Lung Disease Sales by Country (2021-2026) & (K Units)
Table 90. Europe Interventional Lung Disease Revenue by Country (2016-2021e) & (USD Million)
Table 91. Europe Interventional Lung Disease Revenue by Country (2021-2026) & (USD Million)
Table 92. Europe Interventional Lung Disease Sales by Type (2016-2021e) & (K Units)
Table 93. Europe Interventional Lung Disease Sales by Type (2021-2026) & (K Units)
Table 94. Europe Interventional Lung Disease Sales by Application (2016-2021e) & (K Units)
Table 95. Europe Interventional Lung Disease Sales by Application (2021-2026) & (K Units)
Table 96. Asia-Pacific Interventional Lung Disease Sales by Region (2016-2021e) & (K Units)
Table 97. Asia-Pacific Interventional Lung Disease Sales by Region (2021-2026) & (K Units)
Table 98. Asia-Pacific Interventional Lung Disease Revenue by Region (2016-2021e) & (USD Million)
Table 99. Asia-Pacific Interventional Lung Disease Revenue by Region (2021-2026) & (USD Million)
Table 100. Asia-Pacific Interventional Lung Disease Sales by Type (2016-2021e) & (K Units)
Table 101. Asia-Pacific Interventional Lung Disease Sales by Type (2021-2026) & (K Units)
Table 102. Asia-Pacific Interventional Lung Disease Sales by Application (2016-2021e) & (K Units)
Table 103. Asia-Pacific Interventional Lung Disease Sales by Application (2021-2026) & (K Units)
Table 104. South America Interventional Lung Disease Sales by Country (2016-2021e) & (K Units)
Table 105. South America Interventional Lung Disease Sales by Country (2021-2026) & (K Units)
Table 106. South America Interventional Lung Disease Revenue by Country (2016-2021e) & (USD Million)
Table 107. South America Interventional Lung Disease Revenue by Country (2021-2026) & (USD Million)
Table 108. South America Interventional Lung Disease Sales by Type (2016-2021e) & (K Units)
Table 109. South America Interventional Lung Disease Sales by Type (2021-2026) & (K Units)
Table 110. South America Interventional Lung Disease Sales by Application (2016-2021e) & (K Units)
Table 111. South America Interventional Lung Disease Sales by Application (2021-2026) & (K Units)
Table 112. Middle East & Africa Interventional Lung Disease Sales by Country (2016-2021e) & (K Units)
Table 113. Middle East & Africa Interventional Lung Disease Sales by Country (2021-2026) & (K Units)
Table 114. Middle East & Africa Interventional Lung Disease Revenue by Country (2016-2021e) & (USD Million)
Table 115. Middle East & Africa Interventional Lung Disease Revenue by Country (2021-2026) & (USD Million)
Table 116. Middle East & Africa Interventional Lung Disease Sales by Type (2016-2021e) & (K Units)
Table 117. Middle East & Africa Interventional Lung Disease Sales by Type (2021-2026) & (K Units)
Table 118. Middle East & Africa Interventional Lung Disease Sales by Application (2016-2021e) & (K Units)
Table 119. Middle East & Africa Interventional Lung Disease Sales by Application (2021-2026) & (K Units)
Table 120. Direct Channel Pros & Cons
Table 121. Indirect Channel Pros & Cons
Table 122. Interventional Lung Disease Typical Distributors
Table 123. Interventional Lung Disease Typical Customers
List of Figures
Figure 1. Interventional Lung Disease Picture
Figure 2. Global Interventional Lung Disease Sales Market Share by Type in 2020
Figure 3. Bronchoscopes
Figure 4. Respiratory Endotherapy Devices
Figure 5. ENB Systems
Figure 6. Pleuroscopes
Figure 7. Other
Figure 8. Global Interventional Lung Disease Sales Market Share by Application in 2020
Figure 9. Hospital
Figure 10. Emergency Center
Figure 11. Clinic
Figure 12. Global Interventional Lung Disease Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 13. Global Interventional Lung Disease Market Size and Forecast (2016-2026) & (USD Million)
Figure 14. United States Interventional Lung Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Canada Interventional Lung Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. Mexico Interventional Lung Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Germany Interventional Lung Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. France Interventional Lung Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. United Kingdom Interventional Lung Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Russia Interventional Lung Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Italy Interventional Lung Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. China Interventional Lung Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Japan Interventional Lung Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Korea Interventional Lung Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. India Interventional Lung Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Southeast Asia Interventional Lung Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Australia Interventional Lung Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Brazil Interventional Lung Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Egypt Interventional Lung Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Saudi Arabia Interventional Lung Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. South Africa Interventional Lung Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. Turkey Interventional Lung Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 33. Global Interventional Lung Disease Sales (2016-2026) & (K Units)
Figure 34. Global Interventional Lung Disease Production Capacity (2016-2026) & (K Units)
Figure 35. Global Interventional Lung Disease Production Capacity by Geographic Region: 2020 VS 2021
Figure 36. Interventional Lung Disease Market Drivers
Figure 37. Interventional Lung Disease Market Restraints
Figure 38. Interventional Lung Disease Market Trends
Figure 39. Global Interventional Lung Disease Sales Market Share by Manufacturer in 2020
Figure 40. Global Interventional Lung Disease Revenue Market Share by Manufacturer in 2020
Figure 41. Interventional Lung Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 42. Top 3 Interventional Lung Disease Manufacturer (Revenue) Market Share in 2020
Figure 43. Top 6 Interventional Lung Disease Manufacturer (Revenue) Market Share in 2020
Figure 44. Global Interventional Lung Disease Sales Market Share by Region (2016-2026)
Figure 45. Global Interventional Lung Disease Revenue Market Share by Region (2016-2026)
Figure 46. North America Interventional Lung Disease Revenue (2016-2026) & (USD Million)
Figure 47. Europe Interventional Lung Disease Revenue (2016-2026) & (USD Million)
Figure 48. Asia-Pacific Interventional Lung Disease Revenue (2016-2026) & (USD Million)
Figure 49. South America Interventional Lung Disease Revenue (2016-2026) & (USD Million)
Figure 50. Middle East & Africa Interventional Lung Disease Revenue (2016-2026) & (USD Million)
Figure 51. Global Interventional Lung Disease Sales Market Share by Type (2016-2026)
Figure 52. Global Interventional Lung Disease Revenue Market Share by Type (2016-2026)
Figure 53. Global Interventional Lung Disease Price by Type (2016-2026) & (USD/Unit)
Figure 54. Global Interventional Lung Disease Sales Market Share by Application (2016-2026)
Figure 55. Global Interventional Lung Disease Revenue Market Share by Application (2016-2026)
Figure 56. Global Interventional Lung Disease Price by Application (2016-2026) & (USD/Unit)
Figure 57. North America Interventional Lung Disease Sales Market Share by Country (2016-2026)
Figure 58. North America Interventional Lung Disease Revenue Market Share by Country (2016-2026)
Figure 59. North America Interventional Lung Disease Sales Market Share by Type (2016-2026)
Figure 60. North America Interventional Lung Disease Sales Market Share by Application (2016-2026)
Figure 61. Europe Interventional Lung Disease Sales Market Share by Country (2016-2026)
Figure 62. Europe Interventional Lung Disease Revenue Market Share by Country (2016-2026)
Figure 63. Europe Interventional Lung Disease Sales Market Share by Type (2016-2026)
Figure 64. Europe Interventional Lung Disease Sales Market Share by Application (2016-2026)
Figure 65. Asia-Pacific Interventional Lung Disease Sales Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Interventional Lung Disease Revenue Market Share by Region (2016-2026)
Figure 67. Asia-Pacific Interventional Lung Disease Sales Market Share by Region (2016-2026)
Figure 68. Asia-Pacific Interventional Lung Disease Sales Market Share by Application (2016-2026)
Figure 69. South America Interventional Lung Disease Sales Market Share by Country (2016-2026)
Figure 70. South America Interventional Lung Disease Revenue Market Share by Country (2016-2026)
Figure 71. South America Interventional Lung Disease Sales Market Share by Type (2016-2026)
Figure 72. South America Interventional Lung Disease Sales Market Share by Application (2016-2026)
Figure 73. Middle East & Africa Interventional Lung Disease Sales Market Share by Country (2016-2026)
Figure 74. Middle East & Africa Interventional Lung Disease Revenue Market Share by Country (2016-2026)
Figure 75. Middle East & Africa Interventional Lung Disease Sales Market Share by Type (2016-2026)
Figure 76. Middle East & Africa Interventional Lung Disease Sales Market Share by Application (2016-2026)
Figure 77. Sales Channel: Direct Channel vs Indirect Channel
Figure 78. Methodology
Figure 79. Research Process and Data Source
介入腫瘍学の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Interventional oncology is a subspecialty field of interventional radiology that deals with the diagnosis and treatment of cancerand cancer-related problems using targeted minimally invasive procedures performed under image guidance. Scope of the Report: This report studies the Interventional Oncolo…- 介入神経装置の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Interventional neurology refers to endovascular, catheter-based techniques using fluoroscopy and angiography to diagnose and treat vascular disease of the central nervous system. Neurointerventional procedures use imaging technology and are minimally invasive, meaning they can be accomplished throug…
- 世界の神経血管・インターベンショナル神経装置市場 2021：企業別、地域別、種類・用途別 The Neurovascular or Interventional Neurology Devices market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain o…
- 介入脊椎装置の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Interventional spine procedures are used to treat painful spinal conditions. Interventional treatment options are often more efficient and effective than traditional therapy for spinal (back and neck) pain. The new techniques are excellent minimally invasive alternatives to conventional surgery. Lum…
- 世界の診断用心血管インターベンション装置市場 2021：企業別、地域別、種類・用途別 The Diagnostic Interventional Cardiology Devices market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimi…